Wegovy 0.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F23X8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,967
Award facts
- Contract value 100% obligated
- $52,966.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $52,966.63 to AmerisourceBergen Drug Corp for Wegovy 0.5 mg/0.5 mL pen injections on December 11, 2025, with completion anticipated by December 12, 2025. This firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, and represents a non-set-aside award. The contract was competitively awarded through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle extended through December 2026 that enables supply of pharmaceuticals and medical commodities to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and holds significant contract authority across the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates expertise in delivering a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for Wegovy, a GLP-1 receptor agonist medication, reflects the company's continued role in supplying advanced pharmaceutical therapies to support military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F23X8?
SPE2DR26F23X8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F23X8 worth?
The government has obligated $52,967 on SPE2DR26F23X8.
Is contract SPE2DR26F23X8 an order under another contract?
Yes. SPE2DR26F23X8 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F23X8 competed?
The extent of competition for SPE2DR26F23X8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award